Christi van Heek, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 10,526 shares at $4.75 ($50K) on 2022-06-06, disclosed to the SEC on 2022-06-06.
Open-market purchase of $50k CNCE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.